Search Results 1-10 of 17307 for Proto-oncogene

  1. Mayo researchers identify mechanism of oncogene action in lung cancer

    JACKSONVILLE, Fla. — Researchers at Mayo Clinic have identified a genetic promoter of cancer that drives a major form of lung cancer.

  2. Oncogenic Gene Dysregulation and Carcinogenesis - Department of Cancer Biology - Mayo Clinic Research

    The Department of Cancer Biology at Mayo Clinic is studying oncogenic gene dysregulation and carcinogenesis, including the cancer signaling process.

  3. Curriculum - Comprehensive Endocrine Surgery Fellowship (Minnesota) - Mayo Clinic College of Medicine & Science

    During these experiences, the fellow: Learns to recognize endocrine cytology and pathology; Interprets technology — immunostains, RET proto-oncogene, DNA ploidy ...

  4. A flushing disorder: A case from the endocrine teaching clinics

    Bidirectional sequence analysis was performed to test for the presence of a mutation in exons 10, 11, 13, 14, 15 and 16 of the RET proto-oncogene and was ...

  5. Publications - Nathanael G. Bailey, M.D. - Mayo Clinic

    GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms. Blood ... Oncogenic N-Ras and Tet2 haploinsufficiency collaborate to dysregulate ...

  6. Medical Research & Education - Mayo Clinic News Network

    July 2, 2021. Mayo Clinic study suggests patients with lung cancer be screened for MET oncogene featured image ... oncogene. Joe Dangor. July 1, 2021. Newly ...

  7. Medical Research & Education - Mayo Clinic News Network

    Latest stories · Mayo Clinic study suggests patients with lung cancer be screened for MET oncogene featured image · Newly discovered genetic variants in a single ...

  8. Targeting the Cholangiocarcinoma Epigenome - Mayo Clinic Research

    ... oncogenic gene expression. These include homozygous deletions targeting ARID family proteins and histone demethylases (for example, KDM6A), and pathogenic ...

  9. Uncovering Signaling Pathways That Regulate Invasion and Metastasis of Cancer Cells - Tumor Development, Immunology and Progression Laboratory - Mayo Clinic Research

    While PKD1 mediates cell proliferation and also acts as a suppressor of breast tumor cell invasion, PKD3, when expressed, mediates all oncogenic functions.

  10. A Study to Evaluate Immunotherapy for Non-Small Cell Lung Cancer - Mayo Clinic

    (ALK), B-Raf proto-oncogene (BRAF) or ROS proto-oncogene 1 (ROS1) mutations who have not received appropriate therapies targeting these mutations and ...